Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (18947)	4/12/1998 6:36:00 PM
From: WTDEC	Read Replies (3) \| Respond to of 32384

FUGAZI anf HENRY, I have been looking for (in press releases, 10K, etc.) possible off-label uses for Panretin gel, but can't find any. Henry, given your scientific background and knowledge of Panretin gel, do you see any potential off-label use for the gel? If there are any, it would be a huge plus for LGND. Panretin oral, on the other hand, is being tested on a wide variety of cancers as well as psoriasis, so once approval is granted for one indication, off-label use is likely if/once solid trial results are reported for other indications. Regards, Walter